Skip to content

Efficacy of low-level laser therapy in painful disorders

Evaluation for clinical efficacy of wearable low-level laser therapy in patients with chronic painful joint disorder of upper and lower extremities: analysis of placebo-controlled dose-response.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0004916
Enrollment
100
Registered
2020-04-14
Start date
2020-04-20
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The low-level laser therapy devise used commercially available EPIONE-MD1 (Wellscare Co ,, Ltd). Each group will receive a total of three treatment sessions for two weeks. Two weeks o

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Upper and lower extremity joint pain disorder lasting more than 6 months (based on subjective symptom) Korean Version of Pain disability Questionnaire (K-PDQ)> 50/150 Ultrasonographic findings of pain-related abnormalities in soft tissues

Exclusion criteria

Exclusion criteria: Severely deformed osteoarthritis (Kellgran-Lawrence grade IV on X-ray) A history of fractures or surgery involving the associated joint X-rays are accompanied by significant congenital skeletal malformations or severe structural abnormalities. Persistent pain after severe trauma Accompanying neurological symptoms or confirmed by examination (eg neuroma), Pain that persists after an infectious disease Autoimmune diseases Metabolic bone disease Inability to assess organic pain due to psychiatric disorders Maternal or pregnant woman Drugs that affect muscle mass, such as steroids, With malignant tumors The subject or legal representative requested to be opted out of the trial. Use of surgery, drugs, or other medical devices in parallel that may affect safety and efficacy assessments; If serious adverse events are expected Other clinical investigators are suspected of having problems Disagree with the trial

Design outcomes

Primary

MeasureTime frame
Korean Version of Pain disability Questionnaire;visual analogue scale

Secondary

MeasureTime frame
Pain drawing;Korean version of SF-36v2™;Range of motion in a relevant joint;Muscle motor power test in a relevant joint

Countries

Korea, Republic of

Contacts

Public ContactNackhwan Kim

Korea University Anam Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026